Casim A. Sarkar, PhD

Associate Professor, Department of Biomedical Engineering

Casim A. Sarkar

Contact Info

csarkar@umn.edu

Office Phone 612-626-0525

Fax 612-626-6583

Office Address:
Department of Biomedical Engineering
University of Minnesota
7-105 Nils Hasselmo Hall
312 Church Street SE
Minneapolis, MN 55455-0215

Associate Professor, Department of Biomedical Engineering

Preceptor, Medical Scientist Training Program (Combined MD/PhD Training Program)

Faculty, Masters Program in Stem Cell Biology


Postdoctoral Fellow, Biochemistry, University of Zurich, 2002-2005

PhD, Chemical Engineering, Massachusetts Institute of Technology, 2002

BS, Chemical Engineering, University of Texas, Austin, 1997

Summary

Expertise

Systems and synthetic biology approaches for understanding and engineering cellular decision making.

Research

Research Summary/Interests

Protein interaction networks are at the heart of cellular decision making, both in health and disease. Our laboratory uses approaches from biomolecular engineering, synthetic biology, and systems biology to elucidate how protein networks drive a number of developmental and disease-relevant processes, including stem cell differentiation, dormancy induction in cancer, and progression of neurodegenerative diseases.

At a fundamental level, we are particularly interested in elucidating how these protein networks can engender different decisions among individual cells in a population and also how they enable cells to resolve conflicting cues in their environment. Our understanding of how a protein network interfaces with environmental cues also has translational applications in the design of more effective protein and cellular therapeutics.

Using a powerful method known as directed evolution, we can rapidly engineer novel proteins in the laboratory to block or activate key network nodes to modulate the corresponding cell response, such as inhibiting proliferation in cancer. We also construct entirely new protein networks in therapeutic cells with the goal of exploiting such living therapies to enable dynamic drug delivery responses, as is needed, for example, in insulin dosing for diabetics.